Speech-Language Pathologists in Dallastown, PA Accepting Medicare

2 Speech-Language Pathologists found. Showing 1 - 2

Victoria Bowman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 W Queen St, Dallastown, PA 17313 Phone: 717-246-1671

Mrs. Karen B Gillen, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 472 Pulaski Pl, Dallastown, PA 17313 Phone: 717-741-3891

News Archive

Blumenthal defends hew health IT rules to Utah leaders

David Blumenthal, the national coordinator for health information technology for the U.S. Department of Health and Human Services, "defended the administration's new plans against critics who say the watered-down rules miss an opportunity to lower costs and improve patient care," The Salt Lake Tribune reports.

Genaera starts trial of Trodusquemine in overweight and obese type 2 diabetes

Genaera Corporation has announced that dosing of subjects has begun in study MSI-1436C-102 (Study 102), the multiple ascending dose Phase 1b study of trodusquemine (MSI-1436) in overweight and obese type 2 diabetics.

Crohn's disease may be caused by same bacterium that causes Paratuberculosis or Johne's disease in cattle, sheep, and goats

A study in this week's issue of THE LANCET suggests that Crohn's disease may be caused by Mycobacterium avium subspecies paratuberculosis (MAP), the same bacterium that causes a similar intestinal disorder (known as Paratuberculosis or Johne's disease) in cattle, sheep, and goats.

NIAID partners with Liberian government to test ZMapp drug for Ebola virus disease

In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases today launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study, which will be conducted in Liberia and the United States, is a randomized controlled trial enrolling adults and children with known Ebola virus infection.

CT shows promise in predicting COPD exacerbation risk

Measurement of the pulmonary artery-to-aorta ratio can predict the risk for exacerbations in patients with chronic obstructive pulmonary disease, particularly those that require hospitalization, say the authors of a US study.

Read more Medical News

› Verified 7 days ago